Danaher (DHR) – Investment Analysts’ Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of Danaher (NYSE: DHR) recently:

• 10/27/2026 – Danaher was downgraded by DZ Bank from “strong-buy” to “hold”.
• 10/26/2026 – Danaher was upgraded by Wall Street Zen from “hold” to “buy”.
• 10/22/2026 – Danaher had its “buy” rating reaffirmed by UBS Group. They now have a $260.00 price target on the stock.
• 10/22/2026 – Danaher had its “buy” rating reaffirmed by The Goldman Sachs Group. They now have a $275.00 price target on the stock.
• 10/22/2026 – Danaher had its price target raised by Citigroup from $230.00 to $270.00. They now have a “buy” rating on the stock.
• 10/22/2026 – Danaher had its price target raised by Barclays from $255.00 to $260.00. They now have an “overweight” rating on the stock.
• 10/22/2026 – Danaher had its price target raised by TD Cowen from $255.00 to $270.00. They now have a “buy” rating on the stock.
• 10/22/2026 – Danaher had its price target raised by JPMorgan Chase & Co. from $250.00 to $270.00. They now have an “overweight” rating on the stock.
• 10/22/2026 – Danaher had its price target raised by Stifel Nicolaus from $220.00 to $260.00. They now have a “buy” rating on the stock.
• 10/22/2026 – Danaher had its price target raised by Robert W. Baird from $246.00 to $254.00. They now have an “outperform” rating on the stock.
• 10/18/2026 – Danaher was downgraded by Wall Street Zen from “buy” to “hold”.
• 10/13/2026 – Danaher had its price target raised by TD Cowen from $236.00 to $255.00. They now have a “buy” rating on the stock.
• 10/12/2026 – Danaher had its price target raised by Morgan Stanley from $220.00 to $240.00. They now have an “overweight” rating on the stock.
• 10/10/2026 – Danaher was upgraded by Wall Street Zen from “hold” to “buy”.
• 10/7/2026 – Danaher had its price target raised by Barclays from $230.00 to $255.00. They now have an “overweight” rating on the stock.
• 10/5/2026 – Danaher had its price target raised by Royal Bank Of Canada from $215.00 to $250.00. They now have an “outperform” rating on the stock.
• 10/1/2026 – Danaher had its price target raised by Guggenheim from $200.00 to $250.00. They now have a “buy” rating on the stock.
• 9/21/2026 – Danaher had its price target raised by The Goldman Sachs Group from $210.00 to $250.00. They now have a “buy” rating on the stock.
• 9/16/2026 – Danaher was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
• 9/9/2026 – Danaher is now covered by UBS Group. They set a “buy” rating and a $250.00 price target on the stock.
• 9/9/2026 – Danaher was upgraded by UBS Group to “strong-buy”.

Danaher Stock Performance

Shares of NYSE:DHR traded up $4.16 during midday trading on Wednesday, hitting $234.27. The company’s stock had a trading volume of 1,309,574 shares, compared to its average volume of 4,446,487. The stock’s 50 day simple moving average is $219.38 and its 200 day simple moving average is $201.70. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The stock has a market capitalization of $164.81 billion, a price-to-earnings ratio of 38.34, a PEG ratio of 2.86 and a beta of 0.76. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.92 by $0.19. The firm had revenue of $6.55 billion for the quarter, compared to analyst estimates of $6.56 billion. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The company’s revenue was up 8.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.89 EPS. As a group, research analysts anticipate that Danaher Corporation will post 8.59 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher’s dividend payout ratio is currently 26.19%.

Insider Buying and Selling at Danaher

In related news, CAO Christopher Bouda sold 7,598 shares of Danaher stock in a transaction dated Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the sale, the chief accounting officer directly owned 9,107 shares of the company’s stock, valued at $2,136,137.92. This trade represents a 45.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 10.80% of the company’s stock.

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.